MS Therapy Management for Pregnancy May Raise Relapse Risk

(MedPage Today) — Management of disease-modifying therapies (DMTs) for multiple sclerosis (MS) during pregnancy raised relapse risk, especially for certain drugs, French registry data suggested.
Across all MS drugs, DMT management during pregnancy…

Source link : https://www.medpagetoday.com/neurology/multiplesclerosis/116818

Author :

Publish date : 2025-08-04 19:13:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

MS Therapy Management for Pregnancy May Raise Relapse Risk

Fewer Ocular Pressure Spikes With Drug Vials vs Popular Prefilled Syringes

A White House Pandemic Office Is Being Sidelined. Here’s Why That Matters

Related Posts

New Guidance Released on VEXAS Diagnosis and Management

I Was Inside CDC During the Shooting. I Can Still Hear the Bullets.

Med School Diversity Fell After Supreme Court Affirmative Action Ruling

Tamworth brain image doctor banned for assault and racism

JWST gets a closer look at interstellar comet 3I/ATLAS

1 in 3 Childhood Cancer Survivors in LATAM Lack Follow-Up

New Guidance Released on VEXAS Diagnosis and Management

I Was Inside CDC During the Shooting. I Can Still Hear the Bullets.

Med School Diversity Fell After Supreme Court Affirmative Action Ruling

Tamworth brain image doctor banned for assault and racism

JWST gets a closer look at interstellar comet 3I/ATLAS

1 in 3 Childhood Cancer Survivors in LATAM Lack Follow-Up

Major Hospital Dumps United Healthcare; Fewer Qualified Docs; Alcohol and Hair Loss

Artificial Intelligence: Coming Soon to Your Doctor’s Office!

Categories

Archives